Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies - PubMed (original) (raw)
Practice Guideline
. 2011 Sep;42(9):2645-50.
doi: 10.1161/STROKEAHA.111.618850. Epub 2011 Aug 18.
Collaborators, Affiliations
- PMID: 21852620
- DOI: 10.1161/STROKEAHA.111.618850
Practice Guideline
Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies
Gregory W Albers et al. Stroke. 2011 Sep.
Abstract
Background and purpose: The goal of the Stroke Treatment Academic Industry Roundtable (STAIR) meetings is to advance the development of acute and restorative stroke therapies. Summary of Review- At the STAIR VII recommendations for strategies to maximize the use of intravenous thrombolytics through targeting public education, and the refinement of current treatment exclusion criteria were proposed. Increased utilization of mechanical devices for intra-arterial recanalization can be achieved by obtaining more definitive evidence of efficacy in randomized clinical trials, identification of patient characteristics associated with treatment efficacy, optimization of technical approaches, clarification of effective time windows, and development of approaches to limit complications. Neuroprotective strategies remain viable; recommendations for further study of these agents include an emphasis on rapid administration, consideration of the systemic effects of ischemic stroke, prevention of complications associated with early reperfusion, a focus on agents with multiple mechanisms of action, and consideration of possible interactions between neuroprotective and thrombolytic therapies.
Conclusions: Extending intravenous thrombolysis to a broader patient population, clarifying the risk and benefits of intra-arterial reperfusion therapies, and further development of neuroprotective therapies were the key recommendations from STAIR VII.
Similar articles
- Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Higashida RT, et al. Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717 - Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.
Saver JL, Jovin TG, Smith WS, Albers GW, Baron JC, Boltze J, Broderick JP, Davis LA, Demchuk AM, DeSena S, Fiehler J, Gorelick PB, Hacke W, Holt B, Jahan R, Jing H, Khatri P, Kidwell CS, Lees KR, Lev MH, Liebeskind DS, Luby M, Lyden P, Megerian JT, Mocco J, Muir KW, Rowley HA, Ruedy RM, Savitz SI, Sipelis VJ, Shimp SK 3rd, Wechsler LR, Wintermark M, Wu O, Yavagal DR, Yoo AJ; STAIR VIII Consortium. Saver JL, et al. Stroke. 2013 Dec;44(12):3596-601. doi: 10.1161/STROKEAHA.113.002769. Epub 2013 Nov 5. Stroke. 2013. PMID: 24193797 Free PMC article. - Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
Mullen MT, Pisapia JM, Tilwa S, Messé SR, Stein SC. Mullen MT, et al. Stroke. 2012 Sep;43(9):2350-5. doi: 10.1161/STROKEAHA.111.639211. Epub 2012 Jul 17. Stroke. 2012. PMID: 22811451 Review. - Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies.
Molina CA, Saver JL. Molina CA, et al. Stroke. 2005 Oct;36(10):2311-20. doi: 10.1161/01.STR.0000182100.65262.46. Epub 2005 Sep 22. Stroke. 2005. PMID: 16179577 Review. - Acute treatment for ischemic stroke in 2004.
Mohammad YM, Divani AA, Kirmani JF, Harris-Lane P, Qureshi AI. Mohammad YM, et al. Emerg Radiol. 2004 Dec;11(2):83-6. doi: 10.1007/s10140-004-0363-2. Emerg Radiol. 2004. PMID: 15309661 Review.
Cited by
- Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.
Han X, Ren H, Nandi A, Fan X, Koehler RC. Han X, et al. Sci Rep. 2021 May 25;11(1):10885. doi: 10.1038/s41598-021-90216-4. Sci Rep. 2021. PMID: 34035344 Free PMC article. - A cross-species approach using an in vivo evaluation platform in mice demonstrates that sequence variation in human RABEP2 modulates ischemic stroke outcomes.
Lee HK, Kwon DH, Aylor DL, Marchuk DA. Lee HK, et al. Am J Hum Genet. 2022 Oct 6;109(10):1814-1827. doi: 10.1016/j.ajhg.2022.09.003. Epub 2022 Sep 26. Am J Hum Genet. 2022. PMID: 36167069 Free PMC article. - Improving the translation of animal ischemic stroke studies to humans.
Jickling GC, Sharp FR. Jickling GC, et al. Metab Brain Dis. 2015 Apr;30(2):461-7. doi: 10.1007/s11011-014-9499-2. Epub 2014 Feb 15. Metab Brain Dis. 2015. PMID: 24526567 Free PMC article. Review. - The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.
Tanaka M, Ogaeri T, Samsonov M, Sokabe M. Tanaka M, et al. Transl Stroke Res. 2019 Feb;10(1):67-77. doi: 10.1007/s12975-018-0624-0. Epub 2018 Mar 25. Transl Stroke Res. 2019. PMID: 29574659 - Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke.
Ishrat T, Fouda AY, Pillai B, Eldahshan W, Ahmed H, Waller JL, Ergul A, Fagan SC. Ishrat T, et al. J Cereb Blood Flow Metab. 2019 Aug;39(8):1635-1647. doi: 10.1177/0271678X18764773. Epub 2018 Mar 14. J Cereb Blood Flow Metab. 2019. PMID: 29537907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical